Nizatidine and omeprazole enhance the effect of metronidazole on Helicobacter pylori in vitro

被引:12
|
作者
Chen, M
Jensen, B
Zhai, L
Colding, H
Kharazmi, A
Kristiansen, JE
Andersen, LP
机构
[1] Natl Univ Hosp, Rigshosp, Helicobacter Lab, Dept Clin Microbiol, DK-2200 Copenhagen, Denmark
[2] Statens Serum Inst, DK-2300 Copenhagen, Denmark
[3] Univ Copenhagen, Inst Med Microbiol, Copenhagen, Denmark
[4] Sonderborg Hosp, Dept Clin Microbiol, Sonderborg, Denmark
关键词
metronidazole; Helicobacter pylori; nizatidine; omeprazole; susceptibility; resistance;
D O I
10.1016/S0924-8579(01)00489-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Treatment failures are common in patients infected with metronidazole-resist ant Helicobacter pylori in the gastric mucosa when triple therapy including metronidazole is used. In patients with treatment failure and metronidazole-resistant H. pylori, a higher eradication rate for H. pylori was found after secondary treatment with bismuth/ranitidine in combination with antibiotics including metronidazole, compared with the same antibiotics combined with a standard dose of omeprazole. This agrees with our previous finding that bismuth was able to reduce the susceptibility of H. pylori to metronidazole. In this study, we have found that nizatidine, an H-2-receptor antagonist, is also able to reduce the susceptibility of H. pylori to metronidazole in vitro, despite having no direct inhibitory effect on the growth of H. pylori. This agrees with earlier findings that compounds having the ability to reverse antibiotic resistance do not necessarily have an antibiotic or chemotherapeutic effect in the sense of growth inhibition. Therefore, it was decided to investigate the effect of nizatidine and omeprazole on the oxidative respiratory chain, as it is known that metronidazole is able to inhibit the activity of fumarate reductase of H. pylori. This enzyme is a key enzyme in the alternative respiratory chain under anaerobic conditions. Nizatidine was, in these preliminary experiments, found to inhibit fumarate reductase in a dose-dependent way, like metronidazole, whereas omeprazole had almost no effect on fumarate reductase. No other significant effects on the enzymes of the respiratory chain were found. The synergistic effect of nizatidine on metronidazole resistant H. pylori strains could be explained by the effect on fumarate reductase, whereas the effect of omeprazole is different and could be an inhibition of a proton pump in H. pylori. Reversal of antimicrobial resistance with the help of different non-antibiotics seems to be possible by using quite different compounds, and is therefore to be explained by different molecular mechanisms. (C) 2002 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:195 / 200
页数:6
相关论文
共 50 条
  • [21] Antibacterial effect of garlic and omeprazole on Helicobacter pylori
    Jonkers, D
    van den Broek, E
    van Dooren, I
    Thijs, C
    Dorant, E
    Hageman, G
    Stobberingh, E
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (06) : 837 - 839
  • [22] Effect of Temperature on Metronidazole Resistance in Helicobacter pylori
    Gong, Meiliang
    Han, Yingjie
    Wang, Xuning
    Tao, Hongjin
    Meng, Fansen
    Hou, Baicun
    Sun, Benjamin B.
    Wang, Gangshi
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [23] Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer:: Comparison with a historical control
    Schütze, K
    Hentschel, E
    Hirschl, AM
    HEPATO-GASTROENTEROLOGY, 1999, 46 (28) : 2358 - 2362
  • [24] The HOMER study:: The effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection
    Bardhan, KD
    Bayerdörffer, E
    Van Zanten, SJOV
    Lind, T
    Mégraud, F
    Delchier, JC
    Hellblom, M
    Stubberöd, A
    Burman, CF
    Gromark, PO
    Zeijlon, L
    HELICOBACTER, 2000, 5 (04) : 196 - 201
  • [25] A SHORT-COURSE OF OMEPRAZOLE, AMOXICILLIN AND METRONIDAZOLE IN THE TREATMENT OF HELICOBACTER-PYLORI INFECTIONS
    CONNOR, BA
    GASTROENTEROLOGY, 1994, 106 (04) : A64 - A64
  • [26] Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro
    Vogt, K
    Hahn, H
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1998, 48 (06): : 694 - 697
  • [27] Omeprazole, azithromycin and either amoxycillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients
    Vcev, A
    Vceva, A
    Stimac, D
    Takac, B
    Dmitrovic, B
    Kovac, D
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (05) : 453 - 456
  • [28] Amoxicillin/metronidazole/omeprazole/clarithromycin: A new, short quadruple therapy for Helicobacter pylori eradication
    Treiber, G
    Ammon, S
    Schneider, E
    Klotz, U
    HELICOBACTER, 1998, 3 (01) : 54 - 58
  • [29] METRONIDAZOLE, OMEPRAZOLE, AND CLARITHROMYCIN (MOC) - AN EFFECTIVE COMBINATION THERAPY FOR HELICOBACTER-PYLORI INFECTION
    YOUSFI, MM
    ELZIMAITY, HMT
    ALASSI, MT
    COLE, RA
    GENTA, RM
    GRAHAM, DY
    GASTROENTEROLOGY, 1995, 108 (04) : A265 - A265
  • [30] OMEPRAZOLE PLUS ANTIBIOTIC COMBINATIONS FOR THE ERADICATION OF METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI
    BELL, GD
    POWELL, KU
    BURRIDGE, SM
    SPENCER, G
    BOLTON, G
    PURSER, K
    BROOKS, S
    PROSSER, S
    HARRISON, G
    GANT, PW
    JONES, PH
    TROWELL, JE
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1992, 6 (06) : 751 - 758